Back to CRL
Van Berkom & Associates Inc. → CRL
Van Berkom & Associates Inc. CRL Position History
Charles River Laboratories International, Inc. • Healthcare
Quarters held
5
Latest value
$84.1M
Q3 2026
Peak value
$101.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $89.9M |
| Q1 2026 | $86.4M |
| Q1 2026 | $86.4M |
| Q2 2026 | $101.9M |
| Q3 2026 | $84.1M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $84.1M | 285.1K | — | — |
| Q2 2026 | $101.9M | 449.4K | — | — |
| Q1 2026 | $86.4M | 501.2K | — | — |
| Q1 2026 | $86.4M | 501.2K | — | — |
| Q4 2025 | $89.9M | 450.7K | — | — |
Other funds holding CRL
$1.4B
$737.4M
$629.9M
$552.8M